New Research Paper: mRNA COVID-19 Vaccines Are Gene Therapy Products
July 3rd, 2023Via: Epoch Times:
Now that the pandemic has ended, researchers are urging regulatory agencies to consider the safety issues associated with the rapid approval of COVID-19 vaccines—and to correctly classify messenger RNA (mRNA) vaccines as gene therapy products (GTPs) to prevent pharmaceutical companies from bypassing regulatory standards.
Closing the barn door after the horse has gone.